← Product Code [DQF](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQF) · K882723

# ALCON FLUID INJECTOR (K882723)

_Alcon Laboratories · DQF · Nov 8, 1988 · Cardiovascular · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQF/K882723

## Device Facts

- **Applicant:** Alcon Laboratories
- **Product Code:** [DQF](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQF.md)
- **Decision Date:** Nov 8, 1988
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 870.1670
- **Device Class:** Class 2
- **Review Panel:** Cardiovascular

---

**Source:** [https://fda.innolitics.com/submissions/HO/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQF/K882723](https://fda.innolitics.com/submissions/HO/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQF/K882723)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com